US silicone breast implants panel: has FDA regulated fairly?
This article was originally published in Clinica
The Washington Legal Foundation accused the FDA yesterday of violating clearly-established rules governing administrative procedures in its handling of pre-market applications for silicone gel breast implants, writes Karen Riley at the panel meeting.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.
Keeping Track: Oncology Submissions From Blueprint, Y-mAbs, BMS/bluebird; Approvals For BMS’ Reblozyl, LFB’s SevenFact
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.